David Wolk

Affiliations: 
University of Pennsylvania, Philadelphia, PA, United States 
Area:
Memory, aging, Alzheimer's disease
Google:
"David Wolk"
Mean distance: 18.32 (cluster 19)
 
Cross-listing: Alzheimer's Tree

BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Giannini LAA, Xie SX, Peterson C, et al. (2019) Empiric Methods to Account for Pre-analytical Variability in Digital Histopathology in Frontotemporal Lobar Degeneration. Frontiers in Neuroscience. 13: 682
Dolui S, Tisdall D, Vidorreta M, et al. (2019) Characterizing a perfusion-based periventricular small vessel region of interest. Neuroimage. Clinical. 23: 101897
Phillips JS, Da Re F, Irwin DJ, et al. (2019) Longitudinal progression of grey matter atrophy in non-amnestic Alzheimer's disease. Brain : a Journal of Neurology. 142: 1701-1722
Tropea TF, Mak J, Guo MH, et al. (2019) TMEM106B Effect on Cognition in Parkinson's Disease and Frontotemporal Dementia. Annals of Neurology
Giannini LA, Xie SX, McMillan CT, et al. (2019) Divergent Patterns of TDP-43 and Tau Pathologies in Primary Progressive Aphasia. Annals of Neurology
Coughlin DG, Xie SX, Liang M, et al. (2018) Cognitive and Pathological Influences of Tau Pathology in Lewy Body Disorders. Annals of Neurology
Olsson B, Portelius E, Cullen NC, et al. (2018) Association of Cerebrospinal Fluid Neurofilament Light Protein Levels With Cognition in Patients With Dementia, Motor Neuron Disease, and Movement Disorders. Jama Neurology
Sandelius Å, Portelius E, Källén Å, et al. (2018) Elevated CSF GAP-43 is Alzheimer's disease specific and associated with tau and amyloid pathology. Alzheimer's & Dementia : the Journal of the Alzheimer's Association
Bergeron D, Gorno-Tempini ML, Rabinovici GD, et al. (2018) Prevalence of amyloid-β pathology in distinct variants of primary progressive aphasia. Annals of Neurology
Gangishetti U, Christina Howell J, Perrin RJ, et al. (2018) Non-beta-amyloid/tau cerebrospinal fluid markers inform staging and progression in Alzheimer's disease. Alzheimer's Research & Therapy. 10: 98
See more...